Opinion

Video

Expert Perspectives on Navigating Treatment Selection with BTKis in CLL

Faculty provide insights into the selection of BTK inhibitors, emphasizing the role of efficacy, toxicity, and quality of life data in treatment decisions, and exploring the impact of MAIC data.

Related Videos
Yair Lotan, MD, UT Southwestern Medical Center
David C. Fisher, MD
5 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.